RESPIRATORY INFECTION
Clinical trials for RESPIRATORY INFECTION explained in plain language.
Never miss a new study
Get alerted when new RESPIRATORY INFECTION trials appear
Sign up with your email to follow new studies for RESPIRATORY INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug AV-001 aims to help hospitalized pneumonia patients breathe easier
Disease control Recruiting nowThis study tests a new drug called AV-001 in 120 hospitalized adults with pneumonia who need extra oxygen. The drug is given daily for up to 28 days alongside standard care. The goal is to see if it is safe and helps patients recover faster from pneumonia caused by COVID-19 or ot…
Matched conditions: RESPIRATORY INFECTION
Phase: PHASE2 • Sponsor: Vasomune Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New test aims to spot coronaviruses faster and more accurately
Diagnosis Recruiting nowThis study is testing a new diagnostic panel called the BioFire ECoV Panel, designed to detect coronaviruses from leftover nose swab samples. Researchers will enroll 1,500 people and compare the panel's results to standard tests to see how accurate it is. The test is not being us…
Matched conditions: RESPIRATORY INFECTION
Sponsor: BioFire Defense LLC • Aim: Diagnosis
Last updated Jun 27, 2026 07:55 UTC
-
New pill aims to stop recurring chest infections in adults
Prevention Recruiting nowThis study tests whether Buccalin tablets can reduce the number of lower respiratory tract infections in adults who get them often. 240 participants will receive either Buccalin or a placebo for 12 months. The goal is to see if the treatment lowers infection episodes compared to …
Matched conditions: RESPIRATORY INFECTION
Phase: PHASE4 • Sponsor: Laboratorio Farmaceutico SIT srl • Aim: Prevention
Last updated Jun 27, 2026 08:03 UTC